ABC | Volume 113, Nº3, September 2019

Original Article Kang et al. Acute coronary syndrome patients Arq Bras Cardiol. 2019; 113(3):367-372 1. Patel MR, ConteMS, CutlipDE, DibN, Geraghty P , GrayW , et al. Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC). J Am Coll Cardiol. 2015;65(9):931-41. 2. Armstrong EJ, Chen DC, Westin GG, Singh S, McCoach CE, Bang H, et al. Adherence to guideline-recommended therapy is associatedwith decreased major adverse cardio- vascular events andmajor adverse limb events among patientswithperipheralarterydisease.JAmHeartAssoc.2014;3(2):e000697. 3. Go AS, Mozaffarian D , Roger VL, Benjamin EJ, Berry JD , Blaha MJ, et al. Executivesummary:heartdiseaseandstrokestatisticse2014update:areport from the American Heart Association, Circulation 2014;129(3):399-410. 4. JoostenMM, Pai JK, BertoiaML, RimmEB, SpiegelmanD, MittlemanMA, et al. Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men. JAMA. 2012;308(16):1660-7. 5. Rofi M, Patrono C, Colet JP, Mueller C, Valgimigli M, Andreotti F , et al. 2015 ESCGuidelines for themanagement of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology(ESC). Eur Heart J, 2016;37(3):267-315. 6. Chinese Diabetes Society. Chinese guidelines for the prevention and treatment of type 2 diabetes mellitus (2013 Edition). Chin J Endocrinol Metab. 2014;30(10):893-942. 7. ChinaHypertension PreventionGuidelines RevisionCommittee. Guidelines for prevention and treatment of hypertension in China 2010. Chin J Cardiol. 2011;39(7):579-616. 8. Chinese Joint Committee on Guidelines Revision for Prevention and Treatment of Adult Dyslipidemia. Chinese guidelines revision for prevention and treatment of adult dyslipidemia (2016 revised edition). Chin J Cardiol. 2016.4(10):833-53. 9. The BARI Investigators. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multi-vessel disease: the Bypass Angioplasty Revascularization Investigation (BARI). Circulation. 1997;96(6):1761-9. 10. Bertomeu V, Morillas P, Gonzalez-Juanatey JR, Quiles J, Guindo J, Soria F , et al. Prevalence and prognostic influence of peripheral arterial disease in patients>=40 years old admitted into hospital following an acute coronary event. Eur J Vasc Endovasc Surg. 2008;36(2):189-96. 11. Froehlich JB, Mukherjee D, Avezum A, Budaj A, Kline-Rogers EM, López- Sendón J,  et al. Association of peripheral artery disease with treatment and outcomes in acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE). AmHeart J. 2006;151(5):1123-8. 12. Fowkes FG, Rudan D, Rudan I, Aboyans V , Denenberg JO, McDermott MM, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic reviewand analysis. Lancet. 2013; 382(9901):1329-40. 13. GunasekaranP , JeevananthamV , SharmaS, ThapaR, GuptaK. Implicationsof the 2013ACC/AHA cholesterol guidelines on contemporary clinical practice for patients with atherosclerotic coronary and peripheral arterial disease. Indian Heart J. 2017;69(4):464-8. 14. Amrock SM, Abraham CZ, Jung E, Morris PB, Shapiro MD. Risk Factors for Mortality Among IndividualsWith Peripheral Arterial Disease. Am J Cardiol. 2017;120(5):862-7. 15. Wattanakit K, Folosm AR, Selvin E, Weatherley BD, Pankow JS, Brancati FL,  et al. Risk factors for peripheral arterial disease incidence in person with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis. 2005;180(2):389-97. 16. Signorelli SS, Katsiki N. Oxidative stress and inflammation: their role in the pathogenesis of peripheral artery disease with or without type 2 diabetes mellitus. Curr Vasc Pharmacol. 2018;16(6):547-54. 17. Inglis SC, Bebchuk J, Al-Suhaim SA, Case J, Pfeffer MA,  Solomon SD,  et al. Peripheral artery disease and outcomes after myocardial infarction: an individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS,OPTIMAALandVALIANT. Int JCardiol.2013;168(2):1094-101. References Author contributions Conception and design of the research: Yun-Peng K, Li-Ying C, Wen-Xian L; Acquisition of data and Analysis and interpretation of the data: Yun-Peng K, Li-Ying C, Tie-Duo K; Statistical analysis: Tie-Duo K, Wen-Xian L; Writing of the manuscript: Yun‑Peng K, Li-Ying C; Critical revision of the manuscript for intellectual content: Yun-Peng K, Tie-Duo K, Wen-Xian L. Potential Conflict of Interest No potential conflict of interest relevant to this article was reported. Sources of Funding This study was funded by China Cardiovascular Disease Drug Research Foundation. Study Association This study is not associatedwith any thesis or dissertationwork. Ethics approval and consent to participate This article does not contain any studies with human participants or animals performed by any of the authors. 371